Status:
UNKNOWN
Education, Immigration and HPV Vaccination: an Informational Randomized Trial
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Cervical Cancer
Vulvar Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Counteracting misinformation on childhood vaccines remains a priority for public health in industrialized countries. Previous research showed that misinformation-induced vaccine hesitancy particularly...
Detailed Description
In Europe, non-European immigrants display lower vaccination take-up than natives, a higher prevalence of STDs, and lower usage of publicly-funded treatments. Therefore, migrants (and especially women...
Eligibility Criteria
Inclusion
- Resident in Stockholm County, Sweden
- Child attending 5th grade in a school located in the Stockholm County, Sweden
- Mother born in one of the following countries: Sweden, Eritrea, Somalia, Syria, Afghanistan, Iran, Iraq
- Gender: female (sampling among mothers, though we observe also information on their partner, even if male). No gender requirement on the child
Exclusion
- Mother born outside of Sweden and outside of one of the following countries: Eritrea, Somalia, Syria, Afghanistan, Iran, Iraq
- Mother already sampled for another child (i.e. excluding children born from the same mother)
Key Trial Info
Start Date :
April 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 14 2022
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04905030
Start Date
April 28 2021
End Date
January 14 2022
Last Update
June 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet, Medicinsk epidemiologi och biostatistik
Solna, Stockholm County, Sweden, 17165